StonvexLoading…
StonvexStonvexStonvexCore line items from PAVM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $71.00K | $3.00M | $2.45M | $377.00K |
Operating Income | $-21.81M | $-44.49M | $-68.80M | $-91.09M |
Net Income | $401.00K | $39.79M | $-64.17M | $-88.98M |
EPS (Diluted) | $-5.63 | $14.90 | $-9.16 | $-15.03 |
Total Assets | $38.81M | $30.66M | $33.12M | $53.98M |
Total Liabilities | $16.51M | $37.69M | $57.14M | $43.05M |
Cash & Equivalents | $1.54M | $1.19M | $19.64M | $39.74M |
Free Cash Flow OCF − CapEx | $-5.24M | $-33.61M | $-52.28M | $-72.53M |
Shares Outstanding | 927.93K | 373.30K | 8.58M | 6.30M |